ZENSUN SHANGHAI SCIENCE & TECHNOLOGY LTD has a total of 42 patent applications. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), Japan and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are TYMIANSKI MICHAEL, CAN FITE BIOPHARMA LTD and ZENSUN (SHANGHAI) SCIENCE & TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 15 | |
#2 | Japan | 6 | |
#3 | United States | 6 | |
#4 | Republic of Korea | 5 | |
#5 | Canada | 4 | |
#6 | Australia | 3 | |
#7 | China | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement | |
#5 | Foods and drinks | |
#6 | Environmental technology | |
#7 | Consumer goods |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Syringes | |
#6 | Brushes | |
#7 | Climate change adaptation technologies | |
#8 | Natural saccharides | |
#9 | Physical therapy devices | |
#10 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Zhou Mingdong | 40 |
#2 | Mingdong Zhou | 2 |
Publication | Filing date | Title |
---|---|---|
JP2016028094A | Neuregulin based methods for treating heart failure | |
AU2013203483A1 | Extended release of neuregulin for improved cardiac function | |
WO2013053076A1 | Compositions and methods for treating heart failure | |
WO2010142141A1 | Neuregulin based methods for treating heart failure | |
US2011229444A1 | Neuregulin And Cardiac Stem Cells |